MC
ZBH icon

Moors & Cabot’s Zimmer Biomet ZBH Stock Holding History

Moors & Cabot’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,281
Closed -$258K – 946
2025
Q1 		$258K Hold
2,281
– – 0.01% 694
2024
Q4 		$241K Sell
2,281
-36
-2% -$3.86K 0.01% 737
2024
Q3 		$250K Sell
2,317
-164
-7% -$17.9K 0.01% 717
2024
Q2 		$269K Sell
2,481
-1,209
-33% -$143K 0.01% 665
2024
Q1 		$487K Buy
3,690
+1,033
+39% +$129K 0.03% 511
2023
Q4 		$323K Buy
2,657
+50
+2% +$5.58K 0.02% 605
2023
Q3 		$293K Sell
2,607
-20
-0.8% -$2.54K 0.02% 604
2023
Q2 		$382K Buy
2,627
+35
+1% +$4.76K 0.03% 524
2023
Q1 		$335K Sell
2,592
-136
-5% -$17.1K 0.02% 564
2022
Q4 		$348K Buy
2,728
+68
+3% +$7.89K 0.02% 531
2022
Q3 		$278K Sell
2,660
-13
-0.5% -$1.43K 0.02% 584
2022
Q2 		$281K Hold
2,673
– – 0.02% 580
2022
Q1 		$342K Sell
2,673
-29
-1% -$3.5K 0.02% 595
2021
Q4 		$333K Buy
2,702
+298
+12% +$39K 0.02% 588
2021
Q3 		$344K Buy
2,404
+77
+3% +$11.3K 0.02% 553
2021
Q2 		$363K Buy
2,327
+106
+5% +$17.2K 0.03% 513
2021
Q1 		$345K Sell
2,221
-753
-25% -$117K 0.03% 495
2020
Q4 		$445K Sell
2,974
-25
-0.8% -$3.53K 0.04% 407
2020
Q3 		$396K Buy
2,999
+216
+8% +$28.2K 0.04% 386
2020
Q2 		$325K Buy
2,783
+219
+9% +$25.2K 0.03% 430
2020
Q1 		$252K Sell
2,564
-399
-13% -$52.3K 0.04% 434
2019
Q4 		$429K Buy
2,963
+68
+2% +$9.39K 0.04% 378
2019
Q3 		$389K Buy
2,895
+204
+8% +$26.4K 0.04% 381
2019
Q2 		$308K Sell
2,691
-191
-7% -$22.4K 0.04% 406
2019
Q1 		$358K Sell
2,882
-127
-4% -$14.4K 0.05% 348
2018
Q4 		$301K Sell
3,009
-566
-16% -$63.7K 0.05% 366
2018
Q3 		$460K Buy
3,575
+235
+7% +$27.9K 0.06% 326
2018
Q2 		$360K Sell
3,340
-258
-7% -$28.1K 0.05% 376
2018
Q1 		$381K Sell
3,598
-82
-2% -$9.52K 0.05% 376
2017
Q4 		$430K Buy
3,680
+71
+2% +$8.03K 0.06% 346
2017
Q3 		$411K Hold
3,609
– – 0.06% 340
2017
Q2 		$451K Hold
3,609
– – 0.07% 311
2017
Q1 		$426K Hold
3,609
– – 0.07% 314
2016
Q4 		$360K Sell
3,609
-309
-8% -$33.1K 0.06% 344
2016
Q3 		$496K Buy
3,918
+355
+10% +$43.9K 0.08% 269
2016
Q2 		$415K Buy
3,563
+26
+0.7% +$2.94K 0.07% 294
2016
Q1 		$366K Hold
3,537
– – 0.07% 305
2015
Q4 		$353K Sell
3,537
-37
-1% -$3.62K 0.06% 315
2015
Q3 		$326K Buy
3,574
+103
+3% +$10.3K 0.06% 339
2015
Q2 		$368K Sell
3,471
-118
-3% -$13.1K 0.06% 335
2015
Q1 		$411K Buy
3,589
+15
+0.4% +$1.71K 0.07% 309
2014
Q4 		$394K Hold
3,574
– – 0.07% 316
2014
Q3 		$349K Sell
3,574
-225
-6% -$22.1K 0.06% 338
2014
Q2 		$382K Buy
3,799
+412
+12% +$40.2K 0.06% 322
2014
Q1 		$311K Buy
+3,387
New +$312K 0.08% 269

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Moors & Cabot's ZBH Position: Q2 2025 in Review

Moors & Cabot sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 2,281 shares — an estimated $258K sold.

Moors & Cabot first reported a position in ZBH in Q1 2014 and held it in 45 quarters. The position peaked at $496K in Q3 2016. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Moors & Cabot reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Moors & Cabot sold 2,281 Zimmer Biomet shares in Q2 2025, an estimated $258K.
  • Moors & Cabot first reported a position in Zimmer Biomet in Q1 2014 and held it in 45 quarters.
  • Moors & Cabot's Zimmer Biomet position peaked at $496K in Q3 2016.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Moors & Cabot's 13F filing for Q2 2025, filed 6 Aug 2025.